PMV Pharmaceuticals (PMVP) Insider Trading & Ownership $1.51 +0.04 (+2.72%) (As of 04:13 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends PMV Pharmaceuticals (NASDAQ:PMVP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.60%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)2Amount OfInsider Selling(Last 12 Months)$15,163.50 Get PMVP Insider Trade Alerts Want to know when executives and insiders are buying or selling PMV Pharmaceuticals stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PMVP Insider Buying and Selling by Quarter Ad Crypto 101 MediaTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… YES, I WANT THE #1 CRYPTO NOW PMV Pharmaceuticals Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails9/11/2024Deepika JalotaInsiderSell7,218$1.50$10,827.00 9/11/2024Michael CarulliCFOSell2,891$1.50$4,336.50 (Data available from 1/1/2013 forward) PMVP Insider Trading Activity - Frequently Asked Questions Who is on PMV Pharmaceuticals's Insider Roster? The list of insiders at PMV Pharmaceuticals includes Deepika Jalota, Michael Carulli, and Orbimed Advisors Llc. Learn more on insiders at PMVP. What percentage of PMV Pharmaceuticals stock is owned by insiders? 7.60% of PMV Pharmaceuticals stock is owned by insiders. Learn more on PMVP's insider holdings. Which PMV Pharmaceuticals insiders have been selling company stock? The following insiders have sold PMVP shares in the last 24 months: Deepika Jalota ($37,995.48), Michael Carulli ($4,336.50), and Orbimed Advisors Llc ($195,762.78). How much insider selling is happening at PMV Pharmaceuticals? Insiders have sold a total of 101,999 PMV Pharmaceuticals shares in the last 24 months for a total of $238,094.76 sold. PMV Pharmaceuticals Key ExecutivesDr. David H. Mack Ph.D. (Age 62)Co-Founder, CEO, President & Director Compensation: $881.08kDr. Arnold J. Levine Ph.D. (Age 84)Co-Founder, Director & Member of Scientific Advisory Board Compensation: $140kDr. Deepika Jalota Pharm.D. (Age 47)Chief Development Officer Compensation: $593.9kDr. Thomas E. Shenk Ph.D. (Age 77)Co-Founder & Member of Scientific Advisory Board Mr. Michael Carulli (Age 50)Chief Financial Officer 1 recent tradesMr. Robert Ticktin (Age 62)General Counsel, Head of Operations & Company Secretary Mr. Tim SmithSenior VP & Head of Corporate Development and Investor RelationsMs. Crystal ZuckermanVice President of Human ResourcesDr. Binh Vu Ph.D.Senior VP of Drug Discovery & CMCDr. Marc Fellous M.D.Senior VP and Head of Clinical Development & Medical Affairs More Insider Trading Tools from MarketBeat Related Companies TRVI Insider Transactions CRVS Insider Transactions CCCC Insider Transactions ATYR Insider Transactions CADL Insider Transactions AMLX Insider Transactions CMPS Insider Transactions FHTX Insider Transactions FDMT Insider Transactions AVIR Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:PMVP) was last updated on 12/26/2024 by MarketBeat.com Staff From Our PartnersLast time you’ll see this priced at $1.00When was the last time you bought something for a buck? I don’t even think you can buy anything at McDonalds f...StocksToTrade | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowCrypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happen...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredIs Jeff Bezos Crowning the Next Nvidia?It doesn't matter what you think about AI... Because Jeff Bezos's massive load-up on one tiny tech company ...InvestorPlace | SponsoredWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding PMV Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share PMV Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
